A novel method for measuring absolute coronary blood flow & microvascular resistance in patients with ischaemic heart disease

Autor: Morris, P.D., Gosling, R., Zwierzak, I., Evans, H., Aubiniere-Robb, L., Czechowicz, K., Evans, P.C., Hose, D.R., Lawford, P.V., Narracott, A., Gunn, J.P.

Aims\ud \ud Ischaemic heart disease is the reduction of myocardial blood flow, caused by epicardial and/or microvascular disease. Both are common and prognostically important conditions, with distinct guideline-indicated management. Fractional flow r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::84323bd902a983db04195d591b8247c3
https://eprints.whiterose.ac.uk/163597/8/cvaa220.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A novel method for measuring absolute coronary blood flow and microvascular resistance in patients with ischaemic heart disease.

Autor: Morris PD; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK., Gosling R; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK., Zwierzak I; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK., Evans H; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK., Aubiniere-Robb L; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK., Czechowicz K; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK., Evans PC; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK.; The Bateson Centre, University of Sheffield, Sheffield, UK., Hose DR; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK.; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Lawford PV; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK., Narracott AJ; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK., Gunn JP; Mathematical Modelling in Medicine Group, Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield , UK.; Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Insigneo Institute for In Silico Medicine, University of Sheffield, Sheffield, UK.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2021 May 25; Vol. 117 (6), pp. 1567-1577.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome.

Autor: Wolf J; Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital in Brno (FNUSA), Brno, Czech Republic. Electronic address: lupus@gumed.edu.pl., Drozdowski J; Department of Pneumonology and Allergology, Medical University of Gdańsk, Gdańsk, Poland., Czechowicz K; Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland., Winklewski PJ; Institute of Human Physiology, Medical University of Gdańsk, Gdańsk, Poland., Jassem E; Department of Pneumonology and Allergology, Medical University of Gdańsk, Gdańsk, Poland., Kara T; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital in Brno (FNUSA), Brno, Czech Republic; Divisions of Cardiovascular Diseases and Hypertension, Mayo Clinic, Rochester, MN, USA; Department of Cardiology, University Hospital Olomouc, Czech Republic., Somers VK; Divisions of Cardiovascular Diseases and Hypertension, Mayo Clinic, Rochester, MN, USA., Narkiewicz K; Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.

Publikováno v: International journal of cardiology [Int J Cardiol] 2016 Jan 01; Vol. 202, pp. 67-72. Date of Electronic Publication: 2015 Aug 21.